Drug Profile


Alternative Names: Anseculin hydrochloride; Ensaculin hydrochloride; KA 672 hydrochloride

Latest Information Update: 24 Jan 2003

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Unknown
  • Developer Dr. Willmar Schwabe Group
  • Class Coumarins; Neuroprotectants; Nootropics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease

Most Recent Events

  • 24 Jan 2003 Discontinued - Phase-III for Alzheimer's disease in Germany (PO)
  • 05 Feb 2001 KA 672 hydrochloride is now called ensaculin (INN)
  • 05 Feb 2001 Phase-III clinical trials for Alzheimer's disease in Germany (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top